JPRN-UMIN000042885尚未招募未知
Dynamic changes of immune-related molecules of peripheral blood in patients treated immunotherapy with advanced non-small cell lung cancer - ICM-2 study
Tohoku Medical and Pharmaceutical University,Tohoku Medical and Pharmaceutical University Hospital0 个研究点目标入组 50 人开始时间: 2021年1月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients having an overlap cancer with activity Patients that an doctor judged to be inappropriate
研究者
相似试验
进行中（未招募）
1 期
Immunomonitoring anti-PD1 dans le mélanome métastatiqueAdvanced metastatic melanoma in adultsMedDRA version: 18.0Level: PTClassification code 10027480Term: Metastatic malignant melanomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-003120-48-FRHospices Civils de Lyon40
招募中
不适用
Deciphering the functional dynamics of the immune system during (immune)therapy in children with neuroblastomaNeuroblastomaNL-OMON52494Prinses Máxima Centrum voor Kinderoncologie70
尚未招募
1 期
Study for Immune Molecular Mechanism in the Treatment of Sequelae of Pelvic Inflammatory Disease of Accumulated Damp Heat with Penyanxiao in Combination with Pelvic PerfusioITMCTR2000002965Xianyang Central Hospital
招募中
不适用
Observation of changes in comprehensive immune pathology in chemotherapy including Nivolumab for patients with refractory malignant pleural mesotheliomaMalignant pleural mesotheliomaJPRN-UMIN000034312Kawasaki Medical School30
尚未招募
不适用
Characterization of aberrant immune response in post-COVID using innovative signal transduction pathway technology (LC-STP)Long-COVIDPost-COVID1002766510047438NL-OMON56864Academisch Medisch Centrum50